The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Enhancing accurate prediction of survival outcomes and aiding decision making in malignant pleural mesothelioma (MPM) using a three-item index from the LCSS-meso PRO measure: Results from a randomized 444 patient (pt) prospective trial.
James Thomas Symanowski
No relevant relationships to disclose
Richard J. Gralla
No relevant relationships to disclose
Patricia J Hollen
No relevant relationships to disclose